semaglutide drug mounjaro Report reveals a better weight loss than Wegovy Why the Diabetes Drug Mounjaro

It is not medical advice or a substitute for the advice of a physician

There have been anecdotal reports of some patients using these drugs for weight loss and then presenting with repeated episodes of nausea and vomiting secondary to a condition referred to as gastroparesis, said senior author Dr

This mechanism contributes to increased satiety and reduced appetite, which can support weight managementa beneficial effect for many patients with type 2 diabetes, though Ozempic is not licensed specifically for weight management (Wegovy is the licensed semaglutide product for weight management)

Lysates were cleared by centrifugation at 12,000 g for 15 min at 4 C and the supernatants were stored at 80 C until analysis